Published in Br J Biomed Sci on January 01, 2002
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa. Antimicrob Agents Chemother (2006) 1.02
Genome Sequences of Two Pandoraea pnomenusa Isolates Recovered 11 Months Apart from a Cystic Fibrosis Patient. Genome Announc (2015) 0.84
Spectrum of viral infections in patients with cystic fibrosis. Eur J Microbiol Immunol (Bp) (2012) 0.83
Intrinsic Carbapenem-Hydrolyzing Oxacillinases from Members of the Genus Pandoraea. Antimicrob Agents Chemother (2015) 0.78
Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center. BMC Infect Dis (2015) 0.77
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med (2011) 8.73
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med (2015) 5.51
Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med (2008) 3.91
Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. Am J Respir Crit Care Med (2014) 3.50
Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med (2009) 2.52
Extravascular lung water indexed to predicted body weight is a novel predictor of intensive care unit mortality in patients with acute lung injury. Crit Care Med (2010) 2.49
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med (2013) 2.08
Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland. Emerg Infect Dis (2002) 2.04
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One (2012) 2.03
An examination of antibacterial and antifungal properties of constituents described in traditional Ulster cures and remedies. Ulster Med J (2009) 1.92
Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros (2012) 1.79
A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med (2010) 1.67
Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci (2007) 1.47
Community-associated MRSA SCCmec type IVd in Irish equids. Vet Rec (2007) 1.44
MRSA in companion animals. Vet Rec (2006) 1.40
Respiratory viral infection in exacerbations of COPD. Respir Med (2008) 1.35
Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis (2004) 1.25
Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J Cyst Fibros (2010) 1.17
Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res (2009) 1.12
Survival of epidemic strains of nosocomial- and community-acquired methicillin-resistant Staphylococcus aureus on coins. Am J Infect Control (2007) 1.10
Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. Chest (2011) 1.09
Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J Immunol (2009) 1.07
Evaluation of in vitro virulence characteristics of the genus Pandoraea in lung epithelial cells. J Med Microbiol (2008) 1.05
Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. J Antimicrob Chemother (2002) 1.05
An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother (2008) 1.04
Early detection of Pseudomonas aeruginosa--comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Ann Clin Microbiol Antimicrob (2004) 1.04
Clinical trials in cystic fibrosis. J Cyst Fibros (2007) 1.03
Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. Am J Respir Crit Care Med (2006) 1.02
Towards "molecular Esperanto" or the Tower of Babel? (the need for harmonization of techniques for genotyping clinical isolates of Pseudomonas aeruginosa isolated from patients with cystic fibrosis). J Clin Microbiol (2003) 1.01
Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc (2014) 1.00
Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells. Respir Res (2006) 1.00
Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. Pediatr Pulmonol (2006) 0.99
Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis. Med Mycol (2010) 0.99
Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: an overview of five Cochrane systematic reviews. Respir Med (2006) 0.98
The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation. Pediatr Pulmonol (2007) 0.97
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One (2011) 0.95
Molecular detection of CF lung pathogens: current status and future potential. J Cyst Fibros (2013) 0.95
The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Pediatr Pulmonol (2007) 0.95
Biomarkers of fruit and vegetable intake in human intervention studies: a systematic review. Crit Rev Food Sci Nutr (2011) 0.94
Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation. Biochem Soc Trans (2009) 0.94
Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb Pathog (2006) 0.93
Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. J Med Microbiol (2004) 0.93
Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis. J Antimicrob Chemother (2010) 0.93
Validity and reliability of cardiorespiratory measurements recorded by the LifeShirt during exercise tests. Respir Physiol Neurobiol (2009) 0.92
Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients. J Med Microbiol (2003) 0.92
Ureaplasma urealyticum CAPD peritonitis following insertion of an intrauterine device: diagnosis by eubacterial polymerase chain reaction. Perit Dial Int (2002) 0.91
The potential misidentification of Tsukamurella pulmonis as an atypical Mycobacterium species: a cautionary tale. J Med Microbiol (2006) 0.91
Acute and latent adenovirus in COPD. Respir Med (2007) 0.91
Do smokers with chronic obstructive pulmonary disease report their smoking status reliably? A comparison of self-report and bio-chemical validation. Int J Nurs Stud (2011) 0.90
Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor. Am J Physiol Lung Cell Mol Physiol (2007) 0.90
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur Respir J (2012) 0.89
False identification of Coccidioides immitis: do molecular methods always get it right? J Clin Microbiol (2003) 0.88
Comparison of nasal and bronchial epithelial cells obtained from patients with COPD. PLoS One (2012) 0.88
An examination of antibacterial and antifungal properties of constituents of Shiitake (Lentinula edodes) and oyster (Pleurotus ostreatus) mushrooms. Complement Ther Clin Pract (2008) 0.88
Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients. J Cyst Fibros (2011) 0.88
Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis. J Antimicrob Chemother (2013) 0.88
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med (2015) 0.87
Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). J Antimicrob Chemother (2009) 0.87
Effect of cystic fibrosis exacerbations on neutrophil function. Int Immunopharmacol (2005) 0.87
Employment of broad range 16S rDNA PCR and sequencing in the detection of aetiological agents of meningitis. New Microbiol (2005) 0.87
Mucoid Staphylococcus aureus isolated from a patient with a suspected urinary tract infection. J Med Microbiol (2008) 0.87
Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium. J Cyst Fibros (2011) 0.87
Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions. PLoS One (2013) 0.87
A20 regulation of nuclear factor-κB: perspectives for inflammatory lung disease. Am J Respir Cell Mol Biol (2011) 0.86
Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF). J Cyst Fibros (2008) 0.86
Ex vivo diagnosis of lung cancer using a Raman miniprobe. J Phys Chem B (2009) 0.86
Epstein - Barr virus Pneumonitis. Ulster Med J (2009) 0.86
Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus Acapella. Respiration (2005) 0.86
Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD. Chest (2002) 0.86
Comparison of phenotypic and genotypic characteristics of Salmonella bredeney associated with a poultry-related outbreak of gastroenteritis in Northern Ireland. J Infect (2003) 0.85
Emergence of Scedosporium apiospermum in patients with cystic fibrosis. Arch Dis Child (2007) 0.85
Emergence of community-associated MRSA (CA-MRSA) in Northern Ireland. Ulster Med J (2007) 0.85
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. J Cyst Fibros (2011) 0.85
Molecular identification of airborne bacteria associated with aerial spraying of bovine slurry waste employing 16S rRNA gene PCR and gene sequencing techniques. Ecotoxicol Environ Saf (2009) 0.85
Photodynamic Antimicrobial Chemotherapy (PACT) in combination with antibiotics for treatment of Burkholderia cepacia complex infection. J Photochem Photobiol B (2011) 0.85
Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Complement Ther Clin Pract (2008) 0.85
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study. Eur Respir J (2012) 0.85
Characterization of urease-positive thermophilic Campylobacter subspecies by multilocus enzyme electrophoresis typing. Appl Environ Microbiol (2003) 0.84
Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. Ann Am Thorac Soc (2014) 0.84
Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis. J Cyst Fibros (2012) 0.84
Antibiotic and anti-inflammatory therapies for cystic fibrosis. Cold Spring Harb Perspect Med (2013) 0.84
Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis. J Microbiol Methods (2002) 0.84
Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions. Antimicrob Agents Chemother (2013) 0.84
Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2013) 0.84
Zoonoses associated with petting farms and open zoos. Vector Borne Zoonotic Dis (2008) 0.83
Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trial. Arch Phys Med Rehabil (2011) 0.83